pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 8·1 min read
save

Longevity entrepreneur Bryan Johnson reveals he has autoimmune gastritis, a hard-to-diagnose stomach disease

Jul 8, 2026·read at STAT ↗Neutral

Bryan Johnson, known for his longevity ventures, announced on X that he has been diagnosed with autoimmune gastritis.

The condition is a chronic inflammatory disease where antibodies attack stomach cells that produce acid, leading to poor iron absorption and higher risks of stomach cancer, vitamin B12 deficiency, anemia and neurological problems.

Autoimmune gastritis is estimated to affect about 4% of people worldwide, but it is often missed by gastroenterologists, making Johnson’s disclosure a spotlight on the disease’s diagnostic challenges.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Bryan Johnson’s chronic disease is notoriously difficult to diagnose”

read at STAT ↗
1,395 words · retrieved Jul 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Disc Medicine, Inc.6Baylor College of MedicineBeam Therapeutics Inc.LEADINGVera Therapeutics, Inc.
drugs
iron6
topics
Immunology20Oncology5CAR-T3Hematology3Neurology3Gene Therapy (AAV)2Colorectal CancerGastroenterologyInfectious DiseaseMajor DepressionNephrology

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 1d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Jul 8Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study saysSTAT
  • Sep 4Ionis’ rare neurology drug approved; Pfizer inks an ADC dealBioPharma Dive